» back

Waldmann Medical Phototherapy

Will be phased out on 31 March 2020 - but the service organisation will continue to exist.

Luminaire manufacturer Herbert Waldmann GmbH & Co. KG is a medium-sized company in its third generation of family ownership. The product range includes luminaires and lighting systems for offices, industry, care & health as well as systems for medical phototherapy.


In the dermatology sector, Waldmann is renowned as a leading world manufacturer of UV therapy systems and diagnostic luminaires. Waldmann has more than 40 years of experience in the phototherapeutic treatment of skin diseases like psoriasis or atopic eczema. The company has therapy systems in service right around the world that, for the patients and medical specialists involved, are a byword for comfort and safety.


The tangible general downturn in the economy and the extensive new regulations arising in relation to the EU Medical Device Regulation (EU-MDR) make life difficult for many companies. The associated overhead in terms of bureaucracy, personnel and cost is no longer economically tenable for a vast number of SMEs, at the expense of profitability.


For these reasons, Waldmann finds itself compelled to phase out the medical phototherapy business unit with effect from 31 March 2020 in order to safeguard the future efficiency of the Group. Operators of Waldmann UV therapy devices have nothing to fear though. The Group’s own Service organisation remains committed to delivering support and to the provision of spare parts. Legal obligations will be honoured in the process.